pe anti 128 human hla dr antibody Search Results


94
Miltenyi Biotec rea274 fitc 10ul 200k cells bw6 milteyni
Rea274 Fitc 10ul 200k Cells Bw6 Milteyni, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+anti+128+human+hla+dr+antibody/pmc11026387__41467_2024_47057_MOESM5_ESM-42-196-201?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
rea274 fitc 10ul 200k cells bw6 milteyni - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec hla dr dp dq apc miltenyi biotec 130 123 843 rea332
Hla Dr Dp Dq Apc Miltenyi Biotec 130 123 843 Rea332, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+anti+128+human+hla+dr+antibody/pmc10891118__41467_2024_45358_MOESM1_ESM-23-134-135?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
hla dr dp dq apc miltenyi biotec 130 123 843 rea332 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Miltenyi Biotec cd119 fitc
Cytomix increased the expression of immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. The gating strategy is shown in . ( A ) Histogram charts of the expression of the immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. ( B – H ) Cytomix significantly increased the expression levels of HLA-ABC on BM-MSCs and iMSCs WT, HLA-DR on BM-MSCs, CD54 on all types of MSCs, CD200 on iMSCs WT, <t>CD119</t> and CD120b on BM-MSCs, and CD274 on iMSCs WT and iMSCs B2M KO. Representative results of three independent experiments are shown. Results are shown as mean ± SD ( n = 3 in each group) and analysed by two-way ANOVA with Šídák’s multiple comparisons test or Tukey’s multiple comparisons test. */**/***/**** represent comparisons of naïve vs. Cytomix in each type of MSC; $/$$$/$$$$ represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the naïve group; ##/###/#### represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the Cytomix group with significance levels of p < 0.05/0.01/0.001/0.0001, respectively. Nd represents not detectable.
Cd119 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+anti+128+human+hla+dr+antibody/pmc13164479-179-25-32?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
cd119 fitc - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec clone1031
Cytomix increased the expression of immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. The gating strategy is shown in . ( A ) Histogram charts of the expression of the immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. ( B – H ) Cytomix significantly increased the expression levels of HLA-ABC on BM-MSCs and iMSCs WT, HLA-DR on BM-MSCs, CD54 on all types of MSCs, CD200 on iMSCs WT, <t>CD119</t> and CD120b on BM-MSCs, and CD274 on iMSCs WT and iMSCs B2M KO. Representative results of three independent experiments are shown. Results are shown as mean ± SD ( n = 3 in each group) and analysed by two-way ANOVA with Šídák’s multiple comparisons test or Tukey’s multiple comparisons test. */**/***/**** represent comparisons of naïve vs. Cytomix in each type of MSC; $/$$$/$$$$ represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the naïve group; ##/###/#### represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the Cytomix group with significance levels of p < 0.05/0.01/0.001/0.0001, respectively. Nd represents not detectable.
Clone1031, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+anti+128+human+hla+dr+antibody/pmc12630883-288-17-18?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
clone1031 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec kir3dl1 s1 percpvio700
Cytomix increased the expression of immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. The gating strategy is shown in . ( A ) Histogram charts of the expression of the immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. ( B – H ) Cytomix significantly increased the expression levels of HLA-ABC on BM-MSCs and iMSCs WT, HLA-DR on BM-MSCs, CD54 on all types of MSCs, CD200 on iMSCs WT, <t>CD119</t> and CD120b on BM-MSCs, and CD274 on iMSCs WT and iMSCs B2M KO. Representative results of three independent experiments are shown. Results are shown as mean ± SD ( n = 3 in each group) and analysed by two-way ANOVA with Šídák’s multiple comparisons test or Tukey’s multiple comparisons test. */**/***/**** represent comparisons of naïve vs. Cytomix in each type of MSC; $/$$$/$$$$ represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the naïve group; ##/###/#### represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the Cytomix group with significance levels of p < 0.05/0.01/0.001/0.0001, respectively. Nd represents not detectable.
Kir3dl1 S1 Percpvio700, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+anti+128+human+hla+dr+antibody/pm39222660-258-108-119?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
kir3dl1 s1 percpvio700 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

91
Miltenyi Biotec a28 clone rea142 fitc
Primary surface antibody staining panel: Pt25 multilineage panel
A28 Clone Rea142 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+anti+128+human+hla+dr+antibody/pmc10050767-46-4-9?v=Miltenyi+Biotec
Average 91 stars, based on 1 article reviews
a28 clone rea142 fitc - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

94
Miltenyi Biotec apc anti hla dr rea517
Primary surface antibody staining panel: Pt25 multilineage panel
Apc Anti Hla Dr Rea517, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+anti+128+human+hla+dr+antibody/pm38195888-115-33-36?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
apc anti hla dr rea517 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

Image Search Results


Cytomix increased the expression of immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. The gating strategy is shown in . ( A ) Histogram charts of the expression of the immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. ( B – H ) Cytomix significantly increased the expression levels of HLA-ABC on BM-MSCs and iMSCs WT, HLA-DR on BM-MSCs, CD54 on all types of MSCs, CD200 on iMSCs WT, CD119 and CD120b on BM-MSCs, and CD274 on iMSCs WT and iMSCs B2M KO. Representative results of three independent experiments are shown. Results are shown as mean ± SD ( n = 3 in each group) and analysed by two-way ANOVA with Šídák’s multiple comparisons test or Tukey’s multiple comparisons test. */**/***/**** represent comparisons of naïve vs. Cytomix in each type of MSC; $/$$$/$$$$ represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the naïve group; ##/###/#### represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the Cytomix group with significance levels of p < 0.05/0.01/0.001/0.0001, respectively. Nd represents not detectable.

Journal: International Journal of Molecular Sciences

Article Title: Proinflammatory Cytokine Preconditioning Enhances the Therapeutic Potency of Different Types of MSCs in Inflammation

doi: 10.3390/ijms27094090

Figure Lengend Snippet: Cytomix increased the expression of immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. The gating strategy is shown in . ( A ) Histogram charts of the expression of the immunomodulatory markers on BM-MSCs, iMSCs WT and iMSCs B2M KO. ( B – H ) Cytomix significantly increased the expression levels of HLA-ABC on BM-MSCs and iMSCs WT, HLA-DR on BM-MSCs, CD54 on all types of MSCs, CD200 on iMSCs WT, CD119 and CD120b on BM-MSCs, and CD274 on iMSCs WT and iMSCs B2M KO. Representative results of three independent experiments are shown. Results are shown as mean ± SD ( n = 3 in each group) and analysed by two-way ANOVA with Šídák’s multiple comparisons test or Tukey’s multiple comparisons test. */**/***/**** represent comparisons of naïve vs. Cytomix in each type of MSC; $/$$$/$$$$ represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the naïve group; ##/###/#### represent comparisons of BM-MSCs vs. iMSCs WT vs. iMSCs B2M KO in the Cytomix group with significance levels of p < 0.05/0.01/0.001/0.0001, respectively. Nd represents not detectable.

Article Snippet: The cells were centrifuged at 300× g for 5 min and resuspended in 100 μL FACS buffer containing anti-human HLA-ABC-VioGreen, HLA-DR-VioBlue, CD54-APC, CD274-PE-Vio ® 615, CD119-FITC (Cat# 130-120-436, 130-111-794, 130-121-342, 130-122-811, 130-099-931; Miltenyi Biotec, Bergisch Gladbach, Germany), CD120b-PE and CD200-PE-CY7 antibodies (Cat# 358403, 399805; BioLegend, San Diego, CA, USA).

Techniques: Expressing

Primary surface antibody staining panel: Pt25 multilineage panel

Journal: STAR Protocols

Article Title: Chimerism and phenotypic analysis of intraepithelial and lamina propria T cells isolated from human ileal biopsies after intestinal transplantation

doi: 10.1016/j.xpro.2023.102192

Figure Lengend Snippet: Primary surface antibody staining panel: Pt25 multilineage panel

Article Snippet: Mouse monoclonal anti-Human HLA-A2, A28 (clone REA142) FITC , Miltenyi Biotec , Cat#130-099-601; RRID: AB_2652040.

Techniques: Staining

Gating strategy for multilineage chimerism, as well as donor and recipient T cell phenotypes, in post-transplant ileal biopsies, using ITx Pt25 POD241 IEL as an example (A) Representative contour plots depicting gating strategy of HLA-ABC + CD45 + cells, CD3 + T cells, CD3 + γδTCR + T cells, CD3 + γδTCR − CD4 + T cells, CD3 + γδTCR − CD8 + T cells, CD19 + B cells, and CD3 - CD56 + NK cells. (B) Percentages of donor (“D”) and recipient (“R”) multilineage chimerism in Pt25 POD241 IELs. Pt25’s donor is HLA-B12 + . Pt25, the recipient, is HLA-A68 + , which has serological cross-reactivity with HLA-A28. (C) Gating strategy for donor (“D”) and recipient (“R”) CD4 + and CD8 + T cells in Pt25 POD241 IELs. CD45RA vs. CCR7 to categorize naïve T cells (CD45RA + CCR7 + ), central memory T cells (TCMs: CD45RA − CCR7 + ), effector memory T cells (TEMs: CD45RA − CCR7 − ), and terminally-differentiated effector memory T cells (TEMRAs: CD45RA + CCR7 - ), tissue-resident memory T cells (TRMs: CD69 + CD103 +/− CD49a +/ − ), effector T cells (CD28 + NKG2D +/− ).

Journal: STAR Protocols

Article Title: Chimerism and phenotypic analysis of intraepithelial and lamina propria T cells isolated from human ileal biopsies after intestinal transplantation

doi: 10.1016/j.xpro.2023.102192

Figure Lengend Snippet: Gating strategy for multilineage chimerism, as well as donor and recipient T cell phenotypes, in post-transplant ileal biopsies, using ITx Pt25 POD241 IEL as an example (A) Representative contour plots depicting gating strategy of HLA-ABC + CD45 + cells, CD3 + T cells, CD3 + γδTCR + T cells, CD3 + γδTCR − CD4 + T cells, CD3 + γδTCR − CD8 + T cells, CD19 + B cells, and CD3 - CD56 + NK cells. (B) Percentages of donor (“D”) and recipient (“R”) multilineage chimerism in Pt25 POD241 IELs. Pt25’s donor is HLA-B12 + . Pt25, the recipient, is HLA-A68 + , which has serological cross-reactivity with HLA-A28. (C) Gating strategy for donor (“D”) and recipient (“R”) CD4 + and CD8 + T cells in Pt25 POD241 IELs. CD45RA vs. CCR7 to categorize naïve T cells (CD45RA + CCR7 + ), central memory T cells (TCMs: CD45RA − CCR7 + ), effector memory T cells (TEMs: CD45RA − CCR7 − ), and terminally-differentiated effector memory T cells (TEMRAs: CD45RA + CCR7 - ), tissue-resident memory T cells (TRMs: CD69 + CD103 +/− CD49a +/ − ), effector T cells (CD28 + NKG2D +/− ).

Article Snippet: Mouse monoclonal anti-Human HLA-A2, A28 (clone REA142) FITC , Miltenyi Biotec , Cat#130-099-601; RRID: AB_2652040.

Techniques:

Primary surface antibody staining panel: Pt25 B-cell panel

Journal: STAR Protocols

Article Title: Chimerism and phenotypic analysis of intraepithelial and lamina propria T cells isolated from human ileal biopsies after intestinal transplantation

doi: 10.1016/j.xpro.2023.102192

Figure Lengend Snippet: Primary surface antibody staining panel: Pt25 B-cell panel

Article Snippet: Mouse monoclonal anti-Human HLA-A2, A28 (clone REA142) FITC , Miltenyi Biotec , Cat#130-099-601; RRID: AB_2652040.

Techniques: Staining

Journal: STAR Protocols

Article Title: Chimerism and phenotypic analysis of intraepithelial and lamina propria T cells isolated from human ileal biopsies after intestinal transplantation

doi: 10.1016/j.xpro.2023.102192

Figure Lengend Snippet:

Article Snippet: Mouse monoclonal anti-Human HLA-A2, A28 (clone REA142) FITC , Miltenyi Biotec , Cat#130-099-601; RRID: AB_2652040.

Techniques: Recombinant, Saline, Software, Flow Cytometry, Sterility

Journal: STAR Protocols

Article Title: Chimerism and phenotypic analysis of intraepithelial and lamina propria T cells isolated from human ileal biopsies after intestinal transplantation

doi: 10.1016/j.xpro.2023.102192

Figure Lengend Snippet:

Article Snippet: Mouse monoclonal anti-Human HLA-A2, A28 (clone REA142) FITC , Miltenyi Biotec , Cat#130-099-601; RRID: AB_2652040.

Techniques: Concentration Assay, Staining